首页> 外文会议>IEEE Symposium on Computational Intelligence in Control and Automation >Glucose level regulation for diabetes mellitus type 1 patients using FPGA neural inverse optimal control
【24h】

Glucose level regulation for diabetes mellitus type 1 patients using FPGA neural inverse optimal control

机译:糖尿病糖尿病葡萄糖水平调节1患者使用FPGA神经逆最佳控制

获取原文

摘要

In this paper, the field programmable gate array (FPGA) implementation of a discrete-time inverse neural optimal control for trajectory tracking is proposed to regulate glucose level for type 1 diabetes mellitus (T1DM) patients. For this controller, a control Lyapunov function (CLF) is proposed to obtain an inverse optimal control law in order to calculate the insulin delivery rate, which prevents hyperglycemia and hypoglycemia levels in T1DM patients. Besides this control law minimizes a cost functional. The neural model is obtained from an on-line neural identifier, which uses a recurrent high-order neural network (RHONN), trained with an extended Kalman filter (EKF). A virtual patient is implemented on a PC host computer, which is interconnected with the FPGA controller. This controller constitutes a step forward to develop an autonomous artificial pancreas.
机译:在本文中,提出了用于轨迹跟踪的离散时间逆神经系统的现场可编程门阵列(FPGA)实现,以调节1型糖尿病(T1DM)患者的葡萄糖水平。 对于该控制器,提出了一种控制Lyapunov函数(CLF)以获得逆最佳控制法,以便计算胰岛素递送率,这阻止了T1DM患者中高血糖和低血糖水平的胰岛素输送率。 此外,该控制法最大限度地减少了成本职能。 神经模型是从在线神经标识符中获得的,它使用经常性的高阶神经网络(Rhonn),用扩展的卡尔曼滤波器(EKF)训练。 虚拟患者在PC主机上实现,该计算机与FPGA控制器相互连接。 该控制器构成开发自主人工胰腺的一步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号